Lemongrass to Treat Cancer - Quick Reference Sheet

Lemongrass to Treat Cancer

Created on 07/11/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Lemongrass and its lemony oil make cancer cells self-destruct in laboratory dishes and slow tumors in a few animal studies, but it has never been tested as a cancer treatment in people. As food or mild tea it is cheap and generally safe. The evidence does not support using it in place of proven cancer treatments. (Full Review)

Protocol

Preparation
Tea, 1–2 g stalk per cup
No validated anticancer dose
Frequency
1 to a few cups daily
Integrative/traditional practice, not established
Dosing pattern
Split across the day
e.g. morning and evening, given rapid metabolism
Time to effect
Anticancer effect
None established
Not demonstrated in humans
Wellness effects
Immediate–days
Calming, digestive comfort; unrelated to cancer

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Significant hepatic impairment (Child-Pugh Class B or C)
  • Chronic kidney disease
  • Diabetes on insulin or sulfonylureas
  • Known citral or fragrance allergy
  • Active cancer treatment without oncologist's knowledge
Key Interactions
  • CYP450-metabolized drugs (statins, calcium-channel blockers, some chemotherapy)
  • Glutathione-S-transferase–handled drugs
  • OTC sedatives / antihistamines (diphenhydramine, doxylamine)
  • High-dose NSAIDs (ibuprofen, naproxen)
  • Liver-loading botanicals
  • Blood-sugar-lowering supplements (berberine, cinnamon extract, alpha-lipoic acid)
  • Sedative herbs (valerian, kava)
  • Chemotherapy agents (doxorubicin, oxaliplatin-based regimens)

Risk & Side Effects

  • High: Skin sensitization and allergic contact dermatitis; opportunity cost of replacing proven cancer therapy
  • Medium: Gastrointestinal irritation at high doses; blood-sugar lowering
  • Low: Hepatic and renal effects at high doses; dizziness, drowsiness, dry mouth, excess urination
  • Speculative: Pregnancy and uterine-stimulation risk; essential-oil ingestion toxicity and aspiration; drug-metabolism interactions increasing toxicity

Monitoring

Marker Target Why
ALT & AST ALT ~10–26 U/L; AST ~10–26 U/L Liver stress from high-dose oil or extract
Fasting glucose 75–90 mg/dL Blood-sugar-lowering tendency, especially with diabetes medication
eGFR & creatinine eGFR >90 mL/min/1.73m²; creatinine mid-normal Kidney effects linked to excessive lemongrass tea
Complete blood count Within lab normal, stable over time Safety screen given reports of effects on blood cells

Cadence: Baseline before sustained concentrated use, then every 6–12 months (or 4–8 weeks if symptoms appear)

Qualitative Assessment

  • Energy levels and any unusual or persistent fatigue
  • Digestive comfort versus nausea or stomach upset
  • Skin reactions (rash, itching) with topical or oral use
  • Symptoms of low blood sugar such as shakiness, sweating, or lightheadedness
  • Sleep quality and any nighttime urination